David L. Kukis

2.9k total citations
57 papers, 2.4k citations indexed

About

David L. Kukis is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, David L. Kukis has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in David L. Kukis's work include Radiopharmaceutical Chemistry and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Lymphoma Diagnosis and Treatment (14 papers). David L. Kukis is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and Lymphoma Diagnosis and Treatment (14 papers). David L. Kukis collaborates with scholars based in United States, Switzerland and Norway. David L. Kukis's co-authors include Sally J. DeNardo, Gerald L. DeNardo, Claude F. Meares, Robert T. OʼDonnell, Laird Miers, Sui Shen, Linda A. Kroger, Kathleen R. Lamborn, Simon R. Cherry and Gary R. Mirick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

David L. Kukis

57 papers receiving 2.3k citations

Peers

David L. Kukis
Laird Miers United States
Jinhua Zhao China
Bernd Misselwitz Germany
Jianwu Xie United States
Laurent Lemaire France
D G Hirst United Kingdom
Giulio Fracasso Italy
Dengfeng Cheng China
Elaine Jordan United States
Andreas Wunder Germany
Laird Miers United States
David L. Kukis
Citations per year, relative to David L. Kukis David L. Kukis (= 1×) peers Laird Miers

Countries citing papers authored by David L. Kukis

Since Specialization
Citations

This map shows the geographic impact of David L. Kukis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Kukis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Kukis more than expected).

Fields of papers citing papers by David L. Kukis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Kukis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Kukis. The network helps show where David L. Kukis may publish in the future.

Co-authorship network of co-authors of David L. Kukis

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Kukis. A scholar is included among the top collaborators of David L. Kukis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Kukis. David L. Kukis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toyonaga, Takuya, Eric Berg, Krista Fowles, et al.. (2022). Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET). European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3679–3691. 7 indexed citations
2.
Campbell, Kevin T., et al.. (2017). Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications. PLoS ONE. 12(7). e0181484–e0181484. 42 indexed citations
3.
Flannery, Brenna M., Donald A. Bruun, Douglas J. Rowland, et al.. (2016). Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication. Journal of Neuroinflammation. 13(1). 267–267. 74 indexed citations
4.
Smith, Aaron L., Sara M. Freeman, Todd E. Barnhart, et al.. (2016). Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys. Bioorganic & Medicinal Chemistry Letters. 26(14). 3370–3375. 21 indexed citations
5.
Tarantal, Alice F., C. Chang I. Lee, David L. Kukis, & Simon R. Cherry. (2013). Radiolabeling Human Peripheral Blood Stem Cells for Positron Emission Tomography (PET) Imaging in Young Rhesus Monkeys. PLoS ONE. 8(10). e77148–e77148. 15 indexed citations
6.
Kamath, Amrita V., Simon P. Williams, Sherry Bullens, et al.. (2012). Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging. PLoS ONE. 7(9). e45116–e45116. 3 indexed citations
7.
8.
Kukis, David L., Ilse Novak‐Hofer, & Sally J. DeNardo. (2001). Cleavable Linkers to Enhance Selectivity of Antibody-Targeted Therapy of Cancer. Cancer Biotherapy and Radiopharmaceuticals. 16(6). 457–467. 15 indexed citations
9.
OʼDonnell, Robert T., Sally J. DeNardo, Laird Miers, et al.. (2001). Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6. The Prostate. 50(1). 27–37. 47 indexed citations
10.
OʼDonnell, Robert T., Sally J. DeNardo, A. Yuan, et al.. (2001). Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.. PubMed. 7(6). 1561–8. 42 indexed citations
11.
12.
DeNardo, Gerald L., et al.. (2000). 131 I-Lym-1 in Mice Implanted with Human Burkitt's Lymphoma (Raji) Tumors: Loss of Tumor Specificity due to Radiolysis. Cancer Biotherapy and Radiopharmaceuticals. 15(6). 547–560. 10 indexed citations
13.
OʼDonnell, Robert T., Sally J. DeNardo, Gerald L. DeNardo, et al.. (2000). Efficacy and toxicity of radioimmunotherapy with90Y-DOTA-peptide-ChL6 for PC3-tumored mice. The Prostate. 44(3). 187–192. 5 indexed citations
14.
Kukis, David L., et al.. (1999). Stability of Monoclonal Antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 Immunoconjugate with Ultra Freezer Storage. Cancer Biotherapy and Radiopharmaceuticals. 14(5). 363–369. 4 indexed citations
15.
OʼDonnell, Robert T., Bryan R. Leigh, Scott Christensen, et al.. (1999). Radioimmunotherapy of Acquired Immunodeficiency Syndrome (AIDS) Associated Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 14(3). 167–176. 3 indexed citations
16.
DeNardo, Gerald L., Sally J. DeNardo, David L. Kukis, et al.. (1998). Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.. PubMed. 18(4B). 2779–88. 53 indexed citations
17.
DeNardo, Gerald L., David L. Kukis, Sally J. DeNardo, et al.. (1997). Enhancement of67Cu-2IT-BAT-LYM-1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin-2. Cancer. 80(S12). 2576–2582. 8 indexed citations
18.
Meares, Claude F., et al.. (1995). Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.. PubMed. 55(23 Suppl). 5726s–5728s. 10 indexed citations
19.
Kukis, David L., Douglas P. Greiner, Sally J. DeNardo, et al.. (1994). A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer. 73(S3). 779–786. 55 indexed citations
20.
Studer, Martin, Linda A. Kroger, Sally J. DeNardo, David L. Kukis, & Claude F. Meares. (1992). Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymic digestion in vitro and in vivo. Bioconjugate Chemistry. 3(5). 424–429. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laird Miers Breakdown of academic impact, for papers by Jinhua Zhao Breakdown of academic impact, for papers by Bernd Misselwitz Breakdown of academic impact, for papers by Jianwu Xie Breakdown of academic impact, for papers by Laurent Lemaire Breakdown of academic impact, for papers by D G Hirst Breakdown of academic impact, for papers by Giulio Fracasso Breakdown of academic impact, for papers by Dengfeng Cheng Breakdown of academic impact, for papers by Elaine Jordan Breakdown of academic impact, for papers by Andreas Wunder
Rankless by CCL
2026